GURU Among Its Peers
End-of-day Nov 12, 2026 · 1 ETFs by YTD
Loading…
Getting the latest data.
Global X[…]
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.4% | +4.2% | −0.8% | −7.6% | +4.7% | +5.3% | +83.7% | +31.3% | +390.9% |
| S&P 500 · VOO | −0.3% | +3.3% | −1.6% | −2.2% | +11.9% | +12.1% | +80.1% | +73.9% | — |
$19 of every $1,000 in GURU is Ncr
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | VYXNCR Voyix | Technology | 1.90% | $189.55 | 106K | $1.1M |
| 2 | APPApplovin | Technology | 1.81% | $181.15 | 2,614 | $1.1M |
| 3 | LLYELI Lilly | Healthcare | 1.70% | $169.55 | 689 | $990K |
| 4 | VVisa - Shares | Financial Services | 1.66% | $165.61 | 2,273 | $967K |
| 5 | AERAercap | Industrials | 1.64% | $164.32 | 5,422 | $960K |
| 6 | MAMastercard | Financial Services | 1.64% | $164.14 | 1,451 | $959K |
| 7 | UTHRUnited Therapeutics | Healthcare | 1.64% | $163.68 | 1,605 | $956K |
| 8 | AAPLApple | Technology | 1.62% | $162.45 | 2,670 | $949K |
| 9 | CRMSalesforce | Technology | 1.59% | $159.42 | 4,271 | $931K |
| 10 | CAICaris Life Sciences | Healthcare | 1.58% | $158.13 | 38K | $924K |
| 11 | KYMRKymera Therapeutics | Healthcare | 1.55% | $155.12 | 6,719 | $906K |
| 12 | ARQTArcutis Biotherapeutics | Healthcare | 1.55% | $154.77 | 32K | $904K |
| 13 | METAMETA Platforms | Communication Services | 1.54% | $154.37 | 1,434 | $902K |
| 14 | ILMNIllumina | Healthcare | 1.54% | $153.99 | 4,224 | $899K |
| 15 | MSFTMicrosoft | Technology | 1.51% | $151.50 | 1,698 | $885K |
GURU has no close peers in our data yet: […]
No peers with a full year of prices to rank against yet.
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | VYX | NCR Voyix | 1.90% |
| 2 | APP | Applovin - | 1.81% |
| 3 | LLY | ELI Lilly & | 1.70% |
| 4 | V | Visa - Shares | 1.66% |
| 5 | AER | Aercap | 1.64% |
| 6 | MA | Mastercard - A | 1.64% |
| 7 | UTHR | United Therapeutics | 1.64% |
| 8 | AAPL | Apple | 1.62% |
| 9 | CRM | Salesforce | 1.59% |
| 10 | CAI | Caris Life Sciences | 1.58% |
| Fund | Sharpe | Sortino | Volatility | Max DD | Beta | Fee / $10k |
|---|---|---|---|---|---|---|
| GURU | 0.19 | 0.26 | 18.0% | −11.5% | 1.13 | $75 |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 30, 2025 | Jan 7, 2026 | $0.0539 |
| Jun 27, 2025 | Jul 7, 2025 | $0.0173 |
| Dec 30, 2024 | Jan 7, 2025 | $0.0762 |
| Jun 27, 2024 | Jul 5, 2024 | $0.0068 |
| Dec 28, 2023 | Jan 8, 2024 | $0.18 |
| Jun 29, 2023 | Jul 10, 2023 | $0.0526 |
| Dec 29, 2022 | Jan 9, 2023 | $0.0635 |
| Jun 29, 2022 | Jul 8, 2022 | $0.0110 |
| Dec 30, 2021 | Jan 7, 2022 | $0.0422 |
| Dec 30, 2020 | Jan 8, 2021 | $0.90 |
| Jun 29, 2020 | Jul 8, 2020 | $0.30 |
| Dec 30, 2019 | Jan 8, 2020 | $0.0610 |